Clinical trial
EPITRA-14-001: Analysis of the Glutathione Cycle in Children With Rett Syndrome
NCT02360436 is registered in ClinicalTrials.gov with Edison Pharmaceuticals Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- EPITRA-14-001: Analysis of the Glutathione Cycle in Children With Rett Syndrome
- Lead sponsor
- Edison Pharmaceuticals Inc
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- March 31, 2015
- Completion date
- September 30, 2015
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.